These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1485475

  • 21. Success of an outpatient claudication group training program for patients with peripheral arterial occlusive disease (PAOD): the Tübingen model.
    Klyscz T, Jünger M, Jünger I, Hahn M, Rassner G.
    Cent Eur J Public Health; 1997 Mar; 5(1):13-20. PubMed ID: 9150999
    [Abstract] [Full Text] [Related]

  • 22. [Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training].
    Scheffler P, de la Hamette D, Müller H.
    Vasa Suppl; 1991 Mar; 33():350-2. PubMed ID: 1788754
    [Abstract] [Full Text] [Related]

  • 23. Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.
    Spitzer S, Bach R, Schieffer H.
    Int Angiol; 1992 Mar; 11(3):204-10. PubMed ID: 1460355
    [Abstract] [Full Text] [Related]

  • 24. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Dtsch Med Wochenschr; 1987 May 29; 112(22):873-8. PubMed ID: 3556133
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
    Treat-Jacobson D, Bronas UG, Leon AS.
    Vasc Med; 2009 Aug 29; 14(3):203-13. PubMed ID: 19651669
    [Abstract] [Full Text] [Related]

  • 26. Exercise training in intermittent claudication.
    Gibellini R, Fanello M, Bardile AF, Salerno M, Aloi T.
    Int Angiol; 2000 Mar 29; 19(1):8-13. PubMed ID: 10853679
    [Abstract] [Full Text] [Related]

  • 27. Unbalanced risk factors, could compromise the effectiveness of physical training in patients with intermittent claudication?
    Leone A, Laudani R, Definite G, Martini R, Andreozzi GM.
    Minerva Cardioangiol; 2009 Apr 29; 57(2):165-74. PubMed ID: 19274027
    [Abstract] [Full Text] [Related]

  • 28. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Apr 29; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 29. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F.
    Int J Clin Pharmacol Ther; 1999 Jul 29; 37(7):347-51. PubMed ID: 10442509
    [Abstract] [Full Text] [Related]

  • 30. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H, Jung F, Blume J, Spitzer S, Birk A.
    Acta Med Austriaca; 1991 Jul 29; 18 Suppl 1():23-7. PubMed ID: 1719729
    [Abstract] [Full Text] [Related]

  • 31. Abnormal cardiovascular response to exercise in patients with peripheral arterial disease: Implications for management.
    Oka RK, Altman M, Giacomini JC, Szuba A, Cooke JP.
    J Vasc Nurs; 2005 Dec 29; 23(4):130-6; quiz 137-8. PubMed ID: 16326331
    [Abstract] [Full Text] [Related]

  • 32. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
    Diehm C, Kühn A, Strauss R, Hübsch-Müller C, Kübler W.
    Vasa Suppl; 1989 Dec 29; 28():26-30. PubMed ID: 2609241
    [Abstract] [Full Text] [Related]

  • 33. Peripheral arterial insufficiency, effect of physical training on walking tolerance, calf blood flow, and blood flow resistance.
    Dahllöf AG, Holm J, Scherstén T, Sivertsson R.
    Scand J Rehabil Med; 1976 Dec 29; 8(1):. PubMed ID: 935836
    [Abstract] [Full Text] [Related]

  • 34. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Allegra C, Pollari G, Carioti B, Sardina M.
    Int J Clin Pharmacol Ther; 1994 Dec 29; 32(12):646-51. PubMed ID: 7881702
    [Abstract] [Full Text] [Related]

  • 35. Optimizing supervised exercise therapy for patients with intermittent claudication.
    Nicolaï SP, Hendriks EJ, Prins MH, Teijink JA, EXITPAD study group.
    J Vasc Surg; 2010 Nov 29; 52(5):1226-33. PubMed ID: 20692797
    [Abstract] [Full Text] [Related]

  • 36. [The effectiveness of standardized exercise training in intermittent claudication].
    Cachovan M, Scheffler P, Gruss J, Diehm C, Rogatti W.
    Wien Klin Wochenschr; 1994 Nov 29; 106(16):517-20. PubMed ID: 7975662
    [Abstract] [Full Text] [Related]

  • 37. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG, Edwin Langbein W, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN.
    Med Sci Sports Exerc; 2003 Mar 29; 35(3):384-93. PubMed ID: 12618567
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Spitzer S, Gerhards M, Waldhausen P, Wenzel E.
    Wien Med Wochenschr; 1989 Sep 15; 139(17):396-401. PubMed ID: 2480029
    [Abstract] [Full Text] [Related]

  • 40. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication.
    Mika P, Wilk B, Mika A, Marchewka A, Nizankowski R.
    Eur J Cardiovasc Prev Rehabil; 2011 Oct 15; 18(5):754-60. PubMed ID: 21450630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.